chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within seconds of receiving both vaccine updates, I started experiencing left side facial tingling and a dull headache. I rested and seemed to dull effect. My tongue then became numb and tingling. The facial tingling resolved the next morning and tongue symptoms persists. After a week, my lower and upper lip started to tingling on both sides and feel tingling at left cheek. I have no headache or dizziness. No facial paralysis, swelling, or changes in speech. I contacted Occupation Health to report my symptoms on 9/27/17. I proceeded to see my own doctor on 9/28/17 for evaluation of persisting and progression tongue and facial symptoms.
little ache in her arm next day; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administration date 10Mar2021 (Lot number: EN6204, Expiration Date: 30Jun2021) at the age of 62 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Hypertension", start date: Mar2020 (ongoing). Concomitant medication included: LOSARTAN POTASSIUM taken for hypertension, start date: Mar2020 (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 11Mar2021, outcome "recovered" (Mar2021), described as "little ache in her arm next day".  Additional information: The patient had a little ache in her arm next day. She stated that it was quite a bit actually, that was the second day and in the evening but after that she had no problem at all; it was fine. The patient also stated that she was supposed to get the second dose after 3 weeks, it was on the back of her card they have write the 31Mar2021 but they were postponing shots and stretching that to 4 weeks (07Apr2021).   No follow-up attempts are possible. No further information is expected.
Left arm deltoid muscle hurts or has discomfort when raised. Had Flu shot about 3-4 weeks ago.
numbness and tingling in his hand, lips felt puffy and throat was closing, elevated heart rate and b/p rate epinephrine given via pen, and then sent to emergency via ambulance
This is a spontaneous report from a contactable consumer reporting on behalf of the mother of the patient (mother does not wish to be further contacted). A 2-month-old female patient received 4 vaccinations at the same time during a routine well visit in Mar2009. Vaccines were unspecified however PREVENAR 7 was suspected (on routine childhood immunization schedule) but not verified. Relevant medical history, concomitant medications and past product history were not reported. Three days after vaccination, in Mar2009, the patient experienced fever (peaked over 102 degrees Fahrenheit), the child began to vomit and the vaccination site became extremely swollen. The patient was taken to the Emergency Room and was treated with TYLENOL and released. The patient was closely monitored for 4 days. The fever and other symptoms slowly subsided and the child is healthy today with no apparent permanent effects.
chills; This is a spontaneous report from a non-contactable consumer via Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, on unknown date, as dose 2, single for COVID-19 immunization. The patient's medical history includes Type 2 diabetes. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, on an unspecified date, as dose 1, single for covid-19 immunization and experienced excessive sweating. The patient experienced chills. The outcome of the event was unknown at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pain in site, loss of mobility-Went to orthopedic provider- Xrays given. outcome for now is it is a frozen shoulder. medication given for 1 week and then re-evaluate with possible physical therapy
c/o rash (back, face) x 1 wk; tx ATB (po); Nystain for diaper area;
Patient developed malaise and a red swollen face on 3-2-21 after her second vaccination on 2-25-21. She was afebrile, and her doctor instructed her to take OTC Benadryl, which seemed to help. On 3-8-21, her symptoms returned with a persistent headache. Her facial problems came and went over the following month and were accompanied by malaise.  On 5-4-21, patient went to the nurse practitioner at her primary care physician's office and was prescribed 40mg of Prednisone for 5 days. Symptoms returned and worsened 4 days later and she was referred to a dermatologist, who prescribed a longer "step-down" course of Prednisone over a 16 day period, which ended a few days ago, patient reports being asymptomatic at this time.
After vaccination the patient had fatigue and was laying on couch/bed more during the day (his wife also passed away a few months prior).  3 days after vaccination the patient had a syncopal episode in a parking lot. was admitted to hospital was found to have bilateral saddle pulmonary embolism/hemorrhagic shock. Admitted 7/28-8/7/23 and discharged home.
L arm and erythema distal to and at site of injection with warmth or tender to touch.  Patient states that 2 o'clock after injection L arm began to be sore and red and progressed through the day and night.  Patient given Allegra 60mg, Medrol Dose Pack-offered pain med-pt declined pain medicine
SWOLLEN LYMPH NODES , ARM PIT AND LEFT NECK , AND LITTLE BUMPS
This case was reported by a pharmacist via call center representative and described the occurrence of vision decreased in a male patient who received SHINGRIX (batch number 7X743, expiry date 22nd May 2021) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced vision decreased. On an unknown date, the outcome of the vision decreased was unknown. It was unknown if the reporter considered the vision decreased to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist called in to inquire if any information on vision changes with SHINGRIX. The patient experienced decline in vision after receiving 1st dose of SHINGRIX. The health care professional could not provide the patient information.
Vaccines not given at our facitlity.  Advised client to contact vaccinating pharmacy to submit report.--Pharmacy; Client states  beginning 2 days following 2nd dose Moderna vaccine- weakness, progressing to immobility of right thumb and index finger. 6/2/21 - Dx of Extensor tendon rupture and surgery done on 6/8/2021.
CONTACTED PARENTS, PARENTS WERE INFORMED OF THE ISSUE AND GIVEN THE OPTION TO REVACCINATE THEIR CHILD, THEY WERE ALSO CONSULTED TO CONTACT THEIR PEDIATRICIAN.
Patient received MMR vaccination on 1/16/09. 4-5 days later patient developed rash. Patient's HbA1c is elevated but unsure if patient was diagnosed with Diabetes. Unsure if patient developed measles after vaccination. Patient was seen at outside clinic, Dr is having difficulty following up with patient. Unknown current patient's status.
Tinnitus for past 6 weeks starting the night I received the second Moderna vaccine shot. The tinnitus was accompanied by a migraine and 101.8 fever and some nausea and dizziness.  While the migraine and fever subsided, the tinnitus has remained constant for the past six weeks. Also had rash on back of left hand after the first shot - was advised at the site for the second shot that rashes are common and it came back with the second shot though not as bad as with the first shot. The vaccine shot was on left arm, rash on left hand, and tinnitus and hearing loss on left side as well.
Patient started tearing up, feeling tingly lips, coughing, and feeling tightness in the chest/shortness of breathe about 10 minutes after receiving her (second) dose of the Pfizer Covid-19 vaccine. She was then sent to the ER where she is given epinephrine IM, benadryl, steroid, PPI, fluid resuscitation, and albuterol/atrovent for her anaphylactic symptoms. She was also given zofran for her coughing and gagging symtoms. About 3 hours later, she had recovered in the ER and was discharged home.
Pt recvd MMR @ 3PM in rt arm; 8PM last HS had sore throat; This AM temp 101; gave 2 APAP & now 115PM t99; 27AUG91 TC to mom pt fully recovered; Now in school;
Numbness in left cheek and jaw, slight numbness in lips. Movement is normal so far. Numbness down left arm that comes and goes.
I had a bad sore throat on 6/30/2022. I did a PCR test which was positive. I had a PAXLOVID prescription by the afternoon of the same day. It felt like a drain was let loose in my head. I knew something was off. I have been testing negative for the past two days through at home test. I am OCD about COVD-19. The fact that I have it is interesting. This new variant is extremely contagious.
Fever about 24 hours after shot and extreme fatigue.  About  37 hours after shot I woke up, was dizzy, tried to throw up then passed out.  I already had covid 4 months ago.
Pt vaccinated with OPV/DTP developed crying, screaming, prolonged (on & off for 3 days), top of mouth discolored - white; felt "warm", Temp - not taken; Dr. advised mother to obtain DT next time.
no adverse event- patient recieved a flu shot while living at one AFC home and then moved to a new AFC home and recieved a second flu shot 1 month later. It was not communicated between AFC homes that she had already recieved her flu shot.  I traveled to both AFC homes to do yearly flu shots and covid boosters.
Face swelling, swelling in throat  Inside of nose was numb.  These are also reactions to some foods. Uncomfortable but not serious former visit.  Reaction lasted just a little over 12 hours.
Two days after the booster dose of the Pfizer vaccine, the patient developed hives over chest and hands for eight days. Treatment required two Prednisone injections.
Dizziness, Headache, Myalgia, Arthralgia, Fever, NauseaVomiting & Syncope Narrative:
patient was inadvertantly scheduled self on our online system for a second dose of vaccine on our pfizer clinic. Volunteer administered vaccine prior to looking at patients card to realize that patient had received Moderna from faciliity for his first dose. Pfizer was administered in left deltoid. Patient was advised of medication error and advised to monitor symptoms over the next several day. Pt was given Director of Nursing's cell phone number and asked to call with any concerns. Contacted department of health and advised of error. Patient was advised that he does not need to repeat this dose. Currently patient is not exhibiting any adverse symptoms.
pain; Polyarticular Juvenile idiopathic arthritis flare; Extreme Fatigue; FACILITATED COLLECT  This is a solicited report from a non-interventional study based on information received by Pfizer from a regulatory authority. (MFR Control No.: 21k-163-4117526-00). This report was received from a contactable consumer (patient) reporting for himself. A 16-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported) intramuscular on 11Aug2021 (at the age of 16-year-old) as dose 1, single for COVID-19 immunisation, and he started to receive adalimumab (HUMIRA), subcutaneous from unspecified date and ongoing for moderate to severe polyarticular juvenile idiopathic arthritis. The patient's medical history included moderate to severe polyarticular juvenile idiopathic arthritis from unspecified date and ongoing. It was unknown if patient was enrolled in a COVID-19 vaccine trial. The patient's concomitant medications were not reported. On 29Aug2021, the patient experienced polyarticular juvenile idiopathic arthritis flare and extreme fatigue. In 2021, the extreme fatigue resolved. Patient mother reported patient has joint pain that increased from three to ten in his ankles and back. He was hospitalized for pain and flare. He was extremely tired with the flare and had fatigue for almost a month. The patient underwent lab tests and procedures which included pain scale (increased three to ten). The action taken in response to the events for adalimumab dose not changed. The outcome of the events was resolved on 2021 for extreme fatigue, unknown for pain and resolving for polyarticular juvenile idiopathic arthritis flare.   The reporter's assessment of causal relationship of the events with suspect drugs was not provided. The company assessment of causal relationship of the events with bnt162b2 was not provided, while with the suspect drug adalimumab was reported as no reasonable possibility for the events fatigue and polyarticular Juvenile idiopathic arthritis flare, and not reported for pain.  The reporter's assessment of the causal relationship of the events with the suspect product bnt162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information and the drug temporal relationship, the causality between the events Juvenile idiopathic arthritis flare, Fatigue extreme,pain  and  the suspect drug "BNT162B2" cannot be completely excluded.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
This particular lot recalled effective 10/12/2022 due to short dating. Product was unknowingly technically expired at the time of administration
Feel fatigued; make my lymph nodes swell (causing a slight sore throat); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feel fatigued) and LYMPHADENOPATHY (make my lymph nodes swell (causing a slight sore throat)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Feel fatigued) and LYMPHADENOPATHY (make my lymph nodes swell (causing a slight sore throat)). At the time of the report, FATIGUE (Feel fatigued) and LYMPHADENOPATHY (make my lymph nodes swell (causing a slight sore throat)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided.   Reporter did not allow further contact
It was reported that a 48 year old female received a Fluzone SV vaccination on 11/07/2000. Approximately 2 weeks after the injection, the patient developed brachial plexus neuropathy, painful with movement. Further information is requested. From additional correspondence received on 02/21/2001, it was reported that the patient recovered from this experience. Additional patient, vaccine administrator and responsible physician information was also provided.
Nausea, Chills, Headache, Fever, Tired/Sore muscles & joints, irritation to eyes and throat, and cough.
pt recv vax 1NOV96 on 6NOV not feeling well, fatigue-aches 7NOV temp 102 which returned to nl;following wk discomfort achy back of neck on 14NOV;vomiting 18NOV; to urgent care inc discomfort, paralysis, rt side of face advanced to lt
PATIENT RECEIVED DOSE 10/26/17 AROUND 3PM STARTED FEELING BAD NEXT DAY CAME BACK TO PHARMACY 10/28/17 WITH SWOLLEN ARM , PHARMACIST ADVISED TO GO TO WALK IN CLINIC WERE SHE GOT RX FOR PREDNISONE AND CEPHALEXIN FILLED AROUND 1PM ON 10/28  CALLED PT 10/30 WAS FEELING MUCH BETTER SWELLING GOING DOWN CALLED AGAIN TODAY 11/5 FEELING FINE MAYBE  STILL A LITTLE PAIN WHEN SHE LEANS ON ARM OTHERWISE OK  PATIENT RECEIVED PREVNAR ON 5/4/16 PS ALSO RECEIVED HD FLU IN LEFT ARM NO PROBLEM ON 10/26/17 SAME TIME AS PNEUMOVAX.
Pt recv vax on 10/19/98; on 10/21/98 pt exp tender vax site of arm; area red & raised, warm, painful (13 x 14 cm); tx=Prednisone & antibiotic
20FEB97 pt informed nurse that had soreness & discomfort in inj site area where had recv meningococcal vax for 2 wk p/vax given;did not have systemic rxn or require any med tx;no soreness or adverse effects @ this time;
pt reported to MD that about 10 days p/recvd MMR vax presented to MD w/swollen partoid glands & a low white count; MD feels that clinically the pt had mumps;
Fever from about hour after shots given lasted for four days, ear infections in Both ears no previous signs of it in either ear. Hives all over his arms back face legs, hives are still present today. Son also became very ill affecting asthma bringing lost of congestion and these symptoms are still present as well. He was given 6 vaccines not given paperwork in the injection clinic.
This spontaneous report as received from a physician refers to a 6 month old patient of unknown gender. There was no information about medical history/concurrent conditions and concomitant medication. On an unspecified date the patient was vaccinated with the first dose of ROTATEQ (lot# and dose unspecified) and no adverse events reported. The outcome of the event was unknown. Additional information has been requested.
No A/E. Vaccine was stored in freezer for 26 days instead of 14.
BLURRED VISION; CHILLS; GENERALLY DID NOT FEEL WELL; AN ITCHY RASH THAT BROKE OUT ON TORSO; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JUL-2021, the subject experienced an itchy rash that broke out on torso. On 25-JUL-2021, the subject experienced blurred vision. On 25-JUL-2021, the subject experienced chills. On 25-JUL-2021, the subject experienced generally did not feel well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from an itchy rash that broke out on torso, and the outcome of chills, blurred vision and generally did not feel well was not reported. This report was non-serious.
Patient's face and body became very flushed within minutes of injection. She then complained of chest discomfort and lower back pain.
Right arm/shoulder shooting pain with reaching/extension, lasting 15-20 seconds at a time. This happened initially when needle was removed, and then began happening with the movements described above 2 days later. She first saw her primary care physician in January 2021 and has been attending physical therapy since then with minimal improvement. States she completely limited her use of the right arm due to the pain, causing decreased range of motion in the shoulder ("frozen shoulder"). She now has been seen in clinic and was referred to an orthopedic physician.
AT 1:29PM,  PATIENT STATED " I THINK I HAVE HYPOGLYCEMIA" .  PRESPIRATION AND SHAKINESS WAS NOTED. INITIAL VIATALS WERE : BP 148/91,  PR 82, O2 96%, BLOOD SUGAR: 88. JUICE AND SNACKS WAS PROVIDED. PATIENT WAS CLOSELY MONITORED, BLANKET WAS  PROVIDED.  911 WAS CALLED, WHEN THEY ARRIVED PATIENT WAS STABLE AND WAS ABLE TO GO HOME
23 y/o male, w/ 2 day h/o widespread rash w/ pruritus on anterior & posterior trunk b/l arms. Received SPV & AVA # 1 3/7/2010. Medical exam 3/17/2010: 2-> 10mm macules, papules on anterior & posterior trunk, b/l arms. Typical SPV site until 3/15 when following PT, site became increasing red, hot & highly pruritic associated with palpable lymph node left axilla. No respiratory difficulties, other systemic symptoms or fever. As of 3/29/2010 SM reported lesions cleared no itching or systemic symptoms, & SPV site still healing.
This case was reported by a healthcare professional and described the occurrence of leg rash in an adult male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 20 October 2008 at 12:00 the subject received a dose of FLULAVAL, the subject experienced leg rash and itching. Rash on ankles was also reported. At the time of reporting the events were unresolved. The healthcare professional considered the events were possibly related to vaccination with FLULAVAL. The reporter stated that 6 subjects in an employee flu clinic developed a rash on their legs and ankles approximately two days after receiving the FLULAVAL vaccine. The subjects describes the rash as appearing as a heat rash. Two of the subjects were females and treated by a physician with corticosteroids and antihistamines. Some of the subjects were males, but exact details were not known. The healthcare professional reported additional cases see: A0757694A, A0757715A, A0757716A, A0757718A,  and A0757719A. Follow-up information was received on 09 December 2008, via healthcare professional who reported she was not sure if the event was related to the vaccine or not. The healthcare professional stated that 01 December 2008 the complaints were resolved. The reporter stated she was told that two females and three males had a rash. As of this report, the healthcare professional had not received further information. Se did state that two subjects saw their private physicians.
I have received the flu shots annually for at least 10 years without any adverse reactions.  Four days after receiving the reported 2021 flu vaccine, I experienced a genital herpes outbreak.  This is the first outbreak I've had in 20 years.   Nothing else in my routine or diet has changed.  I suspect the flu vaccine I received may have triggered this herpes outbreak.    The outbreak is not severe enough to require any medical attention.  This report is to notify of possible undesired side effect.
Fully vaccinated individual developed COVID 19 symptoms of fever, cough, nasal congestion on 7/7/21
a lump underneath his left armpit; it's painful (lump); uncomfortable pain; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (a lump underneath his left armpit), LYMPH NODE PAIN (it's painful (lump)) and PAIN (uncomfortable pain) in a 64-year-old male patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included hypertension for Hypertension.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced LYMPH NODE PAIN (it's painful (lump)) and PAIN (uncomfortable pain). On an unknown date, the patient experienced LYMPHADENOPATHY (a lump underneath his left armpit). At the time of the report, LYMPHADENOPATHY (a lump underneath his left armpit), LYMPH NODE PAIN (it's painful (lump)) and PAIN (uncomfortable pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) was unknown.       Treatment: Patient took Ibuprofen on 15Feb2021